Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
Clinical trial NCT00235755 · COMPLETED
Trial details
- NCT number
- NCT00235755
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-04-01
- Enrollment
- 539
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.